Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
Top Cited Papers
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1773 (8) , 1263-1284
- https://doi.org/10.1016/j.bbamcr.2006.10.001
Abstract
No abstract availableKeywords
This publication has 189 references indexed in Scilit:
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature Cell Biology, 2003
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylationBiochemical and Biophysical Research Communications, 2002
- Oxidative Stress-induced Phospholipase C-γ1 Activation Enhances Cell SurvivalJournal of Biological Chemistry, 2001
- Tyrosine phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase correlates with high proliferation rates in sublines derived from the Jurkat leukemiaThe International Journal of Biochemistry & Cell Biology, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997